Dermatology

Guselkumab was the first monoclonal antibody targeting the p19 subunit of IL-23 (IL-23p19) to be approved for the treatment of psoriasis.

Prof Augustin opened the symposium by underlining how the management of patients with moderate-to-severe atopic dermatitis (AD) has become more dynamic…

Psoriasis and AD are chronic, systemic inflammatory diseases of the skin characterised by upregulation of proinflammatory cytokines…

The objectives of this symposium were to understand the importance of planning treatment addressing the specific needs of women living…

Type 2 immunity evolved from a dialogue between the immune system and microbes. This form of immunity confers protection against bacteria, viruses…

Prof Schaller posed the question “what makes rosacea so special?” and explained that the manifestations of rosacea are very varied, including papules…

Psoriasis occurs more frequently alongside other IMID, indicating common pathogenetic pathways. Many of these IMID show familial accumulation…

The fumarates, monoethyl fumarate (MEF) and dimethyl fumarate (DMF), are potent ester derivatives of fumaric acid. Fumaric acid esters (FAE)…